alexa Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy.
Oncology

Oncology

Journal of Nuclear Medicine & Radiation Therapy

Author(s): Followill D, Geis P, Boyer A

Abstract Share this page

Abstract PURPOSE: To estimate the dose delivered to patients by photons and neutrons outside the radiation fields when beam intensity modulation conformal radiotherapy is given. These estimates are then used to compute the risk of secondary cancers as a sequela of the radiation therapy. MATERIALS AND METHODS: The x-ray and neutron leakage accompanying two beam-intensity modulation techniques delivered by currently available linear accelerators were estimated for 6-MV, 18-MV, and 25-MV x-ray energies. Estimates of whole-body dose equivalents were determined using leakage measurements reported in the literature and treatment parameters derived for two modulated beam-intensity conformal therapy techniques. Risk values recommended by the National Council on Radiation Protection and Measurements (NCRP) were used to estimate the resulting risk of fatal radiation-induced cancer for 70.00 Gy prescribed tumor doses. RESULTS: The computed worst-case risks of secondary cancers increased in the range from 1.00\% for 6-MV x-rays to 24.4\% for 25-MV x-rays. CONCLUSIONS: Careful consideration should be made of the risks associated with secondary whole-body radiation before implementation of beam intensity modulated conformal therapy at x-ray energies greater than 10 MV.
This article was published in Int J Radiat Oncol Biol Phys and referenced in Journal of Nuclear Medicine & Radiation Therapy

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords